Skip to main content
Michael Stewart, MD, Ophthalmology, Jacksonville, FL, Mayo Clinic Hospital in Florida

MichaelWStewartMD

Ophthalmology Jacksonville, FL

Cataract Related, Retinal Disease

Physician

Dr. Stewart is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Stewart's full profile

Already have an account?

Education & Training

  • University of California Davis Health
    University of California Davis HealthResidency, Ophthalmology, 1988 - 1989
  • Touro Infirmary
    Touro InfirmaryResidency, Ophthalmology, 1987 - 1988
  • Emory University School of Medicine
    Emory University School of MedicineResidency, Ophthalmology, 1984 - 1987
  • University of Miami/Jackson Health System
    University of Miami/Jackson Health SystemInternship, Internal Medicine, 1983 - 1984
  • McGill University Faculty of Medicine
    McGill University Faculty of MedicineClass of 1983

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1988 - Present
  • FL State Medical License
    FL State Medical License 1989 - 2025
  • MN State Medical License
    MN State Medical License 2014 - 2017
  • GA State Medical License
    GA State Medical License 1984 - 1999
  • LA State Medical License
    LA State Medical License 1987 - 1988
  • American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • Fellow (FAAO) American Academy of Ophthalmology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Physicians' Perspective: Desired Changes Among Retina Specialists
    Physicians' Perspective: Desired Changes Among Retina SpecialistsJuly 29th, 2019
  • Alkahest Phase 2a Study AKST4290-202 in Refractory Neovascular AMD Meets Primary and Secondary Endpoints
    Alkahest Phase 2a Study AKST4290-202 in Refractory Neovascular AMD Meets Primary and Secondary EndpointsJuly 29th, 2019
  • Anti-VEGF Drugs Making a Difference in Vision, Longterm Care
    Anti-VEGF Drugs Making a Difference in Vision, Longterm CareJanuary 28th, 2014
  • Join now to see all

Professional Memberships

Hospital Affiliations